首页> 外文期刊>Annals of surgical oncology >Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and a monitor of recurrence of hepatocellular carcinoma after curative liver resection.
【24h】

Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and a monitor of recurrence of hepatocellular carcinoma after curative liver resection.

机译:晶状体凝集素反应性甲胎蛋白的分数可作为预后的标志物,也是根治性肝切除术后肝细胞癌复发的监测器。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The aim of this study was to determine the role of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein (AFP-L3) as a prognostic marker and a monitor marker of recurrence after curative resection of hepatocellular carcinoma (HCC). METHODS: From December 2002 to May 2004, 395 consecutive patients with HCC who underwent curative partial hepatectomy were included in the study. The tumor characteristics and clinical outcomes of patients with positive preoperative and postoperative AFP-L3 were compared with those with negative results. RESULTS: A high ratio of AFP-L3 to total AFP was an indicator of pathologic aggressiveness. Patients with positive preoperative AFP-L3 had significantly earlier recurrence (median time to recurrence 22.0 +/- 2.4 months vs 45.0 +/- 6.9 months, P < .001) when compared with those with negative preoperative results. Significantly more patients with continuously positive or negative-turn-positive AFP-L3 results after surgery developed recurrence, particularly distant metastases, when compared with patients with continuously negative AFP-L3 results. The overall and disease-free survivals were significantly shorter in the positive than the negative preoperative AFP-L3 group. The overall and disease-free survivals were significantly shorter in the continuously positive and the negative-turn-positive than the continuously negative postoperative AFP-L3 group. CONCLUSION: Positive preoperative AFP-L3 and continuously positive or negative-turn-positive AFP-L3 results after surgery predicted a more aggressive tumor behavior, higher tumor recurrence, and poorer clinical outcomes. HCC patients with an increased proportion of AFP-L3 to total AFP should be more aggressively treated and closely followed-up.
机译:摘要背景:这项研究的目的是确定扁桃体凝集素反应性α-甲胎蛋白(AFP-L3)作为肝癌(HCC)根治性切除后的预后标志物和复发监测标志物的作用。方法:从2002年12月至2004年5月,本研究纳入了395例行根治性肝切除术的HCC患者。将术前和术后AFP-L3阳性的患者的肿瘤特征和临床结局与阴性结果进行比较。结果:AFP-L3与总AFP的高比率是病理攻击性的指标。与术前结果阴性的患者相比,术前AFP-L3阳性的患者复发的时间要早​​得多(中位复发时间为22.0 +/- 2.4个月vs 45.0 +/- 6.9个月,P <.001)。与AFP-L3持续阴性的患者相比,手术后AFP-L3持续阳性或阴性的患者明显复发,尤其是远处转移。术前AFP-L3阳性组的总生存期和无病生存期明显短于阳性组。持续阳性和阴性转身阳性患者的总生存率和无病生存时间明显短于持续阴性的术后AFP-L3组。结论术前AFP-L3阳性和转弯后AFP-L3连续阳性或阴性结果预示着肿瘤的侵袭性更大,肿瘤复发率更高,临床预后更差。 AFP-L3在总AFP中所占比例增加的HCC患者应接受更积极的治疗,并密切随访。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号